Evidence map›Paper›PMID 36709495›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2023

Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma.

Yongxu Jia, Baifeng Zhang, Chunyang Zhang, Dora Lai-Wan Kwong, Zhiwei Chang, Shanshan Li, Zehua Wang, Huiqiong Han, Jing Li, Yali Zhong and 4 more

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 77 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Identification of a distinct cluster of LY6EBritish journal of cancer · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Yongxu JiaDepartment of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
Baifeng ZhangDepartments of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518009, P. R. China.ORCID 0000-0003-1966-2285
Chunyang ZhangDepartment of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
Dora Lai-Wan KwongDepartments of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518009, P. R. China.
Zhiwei ChangDepartment of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
Shanshan LiDepartments of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518009, P. R. China.
Zehua WangDepartment of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
Huiqiong HanDepartment of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
Jing LiDepartment of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
Yali ZhongDepartment of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
Xin SuiDepartment of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
Li FuGuangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and International Cancer Center, Shenzhen University Health Science Center, Shenzhen, 518060, P. R. China.
Xinyuan GuanDepartments of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518009, P. R. China.ORCID 0000-0002-4485-6017
Yanru QinDepartment of Clinical Oncology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, 450052, P. R. China.
First Affiliated Hospital of Zhengzhou University · CNChinese University of Hong Kong · HKShenzhen University Health Science Center · CNUniversity of Hong Kong - Shenzhen Hospital · CN

Funding

National Natural Science Foundation of China 81772554National Natural Science Foundation of China 82072738RGC Collaborative Research Fund C4039-19GFRGC Collaborative Research Fund C7026-18GFRGC Collaborative Research Fund C7065-18GFRGC Research Impact Fund R1020-18FRGC Research Impact Fund R4017-18RGC Research Impact Fund R7022-20Science and Technology Foundation of Shenzhen Grant KQTD20180411185028798Shenzhen Fundamental Research Program JCYJ20180508153249223
6 · The paper itself

Abstract

Lymph node metastasis, the leading cause of mortality in esophageal squamous carcinoma (ESCC) with a highly complex tumor microenvironment, remains underexplored. Here, the transcriptomes of 85 263 single cells are analyzed from four ESCC patients with lymph node metastases. Strikingly, it is observed that the metastatic microenvironment undergoes the emergence or expansion of interferon induced IFIT3

Indexed as

Carcinoma, Squamous CellEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaApolipoproteins EEcosystemHumansTranscriptomeTumor MicroenvironmentApolipoproteins Ebioinformaticsesophageal squamous carcinomaimmunofluorescence and immunohistochemistrylymph node metastatic microenvironmentsingle cell RNA sequencing

Identifiers

PMID36709495
PMCPMC9982558
OpenAlexW4318451116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.